Shanghai Aladdin Biochemical Technology Co.,Ltd. engages in the research and development, production, and sale of scientific research reagents for chemistry, life science, analytical chromatography, and material science fields in China. The company’s products include chemistry and biochemicals compounds, including building blocks, ligand, catalysts, chemical synthesis, lab chemicals, chemical biology, reference materials, CVD and ALD precursors, and stable isotopes; material science solutions for energy, electronic, and biomedical materials; and bioactive small molecules comprising compound libraries, natural products, metabolites, ligand families, PROTACs, molecular glues and other degrades, fluorescence imaging, antimalarial ligands, approved ligands, WHO, synthetic organic ligands, endogenous peptide in human, mouse or rat, other peptides, antibodies, laballed ligands, ligands of immunopharmacology, and antibacterial ligands. It offers proteins compounds, consisting of cytokines and growth factors, receptors and cell surface markers, target proteins, CD antigens, streptavidin conjugates, signaling proteins, microbiology and virology, recombinant protein, native protein, animal free protein, enzymes, protein electrophoresis and Western blotting, protein purification, and protein analysis reagents; and antibodies products, such as flow cytometry, cell marker, polyclonal, tags, isotype control, primary, recombinant, secondary, therapeutic, and monoclonal antibodies, as well as loading controls and cell and tissue lysates. In addition, the company provides molecular biology products; and PharmPure, a good manufacturing practices platform. It offers its reagents products under the Aladdin brand and its experimental consumables under the Core Silicon Valley name through aladdin-e.com, an e-commerce platform. The company was founded in 2009 and is headquartered in Shanghai, China.
Metrics to compare | 688179 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688179PeersSector | |
---|---|---|---|---|
P/E Ratio | 47.9x | 46.4x | 2.2x | |
PEG Ratio | 2.93 | 0.16 | 0.00 | |
Price/Book | 4.7x | 2.1x | 1.6x | |
Price / LTM Sales | 8.8x | 3.3x | 1.3x | |
Upside (Analyst Target) | −8.7% | 1.9% | 21.1% | |
Fair Value Upside | Unlock | 1.8% | 1.3% | Unlock |